YAO, Wen et al. Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation: Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF. Mediterranean Journal of Hematology and Infectious Diseases, [S. l.], v. 14, n. 1, p. e2022025, 2022. DOI: 10.4084/MJHID.2022.025. Disponível em: https://www.mjhid.org/mjhid/article/view/4856. Acesso em: 22 jul. 2024.